Glicaramide

This classification denotes an anti-diabetic agent with the molecular formula C30H42N6O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) UK5SR22C8Q, chemically known as 1-cyclohexyl-3-((p-(2-(1-ethyl-4-(isopentyloxy)-3-methyl-1h-pyrazolo(3,4-b)pyridine-5-carboxamido)ethyl)phenyl)sulfonyl)urea but more generally known as glicaramide, which bears US NIH Compound Identifier 65799. European Medicines Agency schedules Glicaramide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07919MIG. The term GLICARAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 27, No. 10 1973, List 13). GLICARAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule glicaramide under HS 29350090 and SITC 51580. As of Q4 2014, GLICARAMIDE remains US FDA's Preferred Term for this commodity. Glicaramide bears US NLM identifiers UMLS ID C0603303 and NCI Concept Code C72945. SMILES: S(=O)(=O)(NC(=O)NC1CCCCC1)C1CCC(CCNC(=O)C2C(OCCC(C)C)C3C(N(NC3C)CC)NC2)CC1.